The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at ...

The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus ...

The U.S. Food and Drug Administration on Thursday announced the names of nine products, under a new fast-track review process ...

Improving drug ads by requiring them to present benefit and harm data can be a powerful tool for adding needed transparency ...

President Donald Trump announced guidance encouraging employers to offer fertility benefits and a plan to cut the cost of ...

Glucagon-like peptide-1 drugs appear to slow the speed at which alcohol enters the bloodstream, which diminishes its effects ...

President Trump announced a pair of efforts Thursday aimed at expanding access to in vitro fertilization (IVF) as he seeks to ...

WASHINGTON (AP) — Drugmaker EMD Serono will reduce the cost of a common fertility medication through a deal struck with the ...

A gene therapy from Regeneron, a pancreatic cancer medicine from Revolution Medicines and a porphyria drug from Disc Medicine ...

FDA announced the first nine recipients of priority review vouchers, which offers expedited drug review to products aligned ...

EMD Serono will sell fertility drugs on the Trump direct-to-consumer marketplace. Trump also preview plans to encourage ...

The FDA's rejections of Replimune and Capricor therapies show how instability threatens biotech innovation, CEOs say.